Affiliation:
1. Department of Cancer Research, Merck Research Laboratories, West Point, PA 19486, USA.
Abstract
Cancer as a disease in the human population is becoming a larger health problem, and the medicines used as treatments have clear limitations. In the past 20 years, there has been a tremendous increase in our knowledge of the molecular mechanisms and pathophysiology of human cancer. Many of these mechanisms have been exploited as new targets for drug development in the hope that they will have greater antitumor activity with less toxicity to the patient than is seen with currently used medicines. The fruition of these efforts in the clinic is just now being realized with a few encouraging results.
Publisher
American Association for the Advancement of Science (AAAS)
Reference53 articles.
1. Kaelin W. G., J. Clin. Invest. 104, 1503 (1999).
2. B. A. Chabner C. J. Allegra G. A. Curt P. Calabresi in Goodman and Gilman's the Pharmacological Basis of Therapeutics J. G. Hardman A. G. Gilman L. E. Limbird Eds. (McGraw-Hill New York 1996) pp. 1233–1287.
3. Molecular themes in oncogenesis
4. J. A. Oates in (2) pp. 780–808.
5. The Hallmarks of Cancer
Cited by
428 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献